Health Wire Burundi: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire Burundi.

Press releases published on May 26, 2026

9 hours ago

Santhera’s Shareholders Approve all Board Proposals at Today’s Annual General Meeting

Indeterminate GlobeNewswire

9 hours ago

ASDS Launches Enhanced Format for DermSurgery Digest Podcast

Indeterminate GlobeNewswire

10 hours ago

NodThera Announces the Publication and Presentation of Cardiometabolic Clinical Data Supporting the Potential of Ruvonoflast to Treat Inflammation at the Source

Indeterminate GlobeNewswire

10 hours ago

Silexion Therapeutics Announces 1-for-10 Reverse Share Split

Indeterminate GlobeNewswire

10 hours ago

Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences

Indeterminate GlobeNewswire

10 hours ago

RenovoRx Announces Promising Pharmacokinetic Data Using the TAMP™ Platform Presented at the 2026 ASCO Annual Meeting

Indeterminate GlobeNewswire

10 hours ago

Allogene Therapeutics Announces Participation in Upcoming Investor Conferences

Indeterminate GlobeNewswire

10 hours ago

Microbot Medical® Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY® Endovascular Robotic System

Indeterminate GlobeNewswire

10 hours ago

Clearmind Medicine Announces Johns Hopkins IRB Approval to Advance CMND-100 Phase I/II Clinical Trial to the Next Parts

Indeterminate GlobeNewswire

10 hours ago

AiM Medical Robotics Announces Collaboration Agreement with Siemens Healthineers to Advance MRI-Guided Robotic Neurosurgery

Indeterminate GlobeNewswire

10 hours ago

60 Degrees Pharmaceuticals Announces Early Enrollment of First Seasonal Patient in Clinical Trial of Tafenoquine for Patients Hospitalized with Babesiosis

Indeterminate GlobeNewswire

10 hours ago

VVT Med Announces First Patients Treated with VVT’s ScleroSafe™ System in Italy

Indeterminate GlobeNewswire

10 hours ago

Artios Announces First Patient Dosed in Randomized Phase 2 POLKA Study Evaluating DNA Polymerase Theta Inhibitor ART6043 in gBRCA-mutated HER2-Negative Breast Cancer

Indeterminate GlobeNewswire

10 hours ago

Nu-Tek BioSciences Fuels Animal-Free Raw Materials Revolution, Joins Minnesota Pavilion #4507 at BIO 2026

Indeterminate GlobeNewswire

10 hours ago

Nu-Tek BioSciences treibt die Revolution im Bereich tierfreier Rohstoffe voran, Teil des Minnesota Pavilion #4507 auf der BIO 2026

Indeterminate GlobeNewswire

10 hours ago

Nu-Tek BioSciences accélère la révolution des matières premières sans origine animale et rejoint le pavillon du Minnesota #4507 au salon BIO 2026

Indeterminate GlobeNewswire

10 hours ago

Esperion Presents New Data from CLEAR Outcomes and the CLEAR PATH Phase 2 Pediatric Study at the European Atherosclerosis Society Congress 2026

Indeterminate GlobeNewswire

10 hours ago

BioVie Announces Full Enrollment of the ADDRESS-LC Trial of Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID

Indeterminate GlobeNewswire

10 hours ago

MBX Biosciences to Present at the Jefferies 2026 Global Healthcare Conference in New York City

Indeterminate GlobeNewswire

10 hours ago

Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences

Indeterminate GlobeNewswire